Surface Oncology Inc. (NASDAQ:SURF) went up by 17.35% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $6.56 to trade ended Tuesday trading at $5.59. This is up from the $5.59 price recorded on Monday’s trading session. Thanks to this latest performance, SURF is closer to the higher price 52-week target of $12.00 and further from the lowest price target of $9.00. Its performance from the start of the year has also been positive, with SURF up by 248.94% year-to-date.
Surface Oncology Inc. (SURF) started the day trading at $5.52 and recorded an intraday high of $6.65. It also recorded an intraday low of $5.4501 during Tuesday’s trading session. Surface Oncology Inc. is a very active stock that recorded a trading volume that is less than -91.38% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 1081627, which is less than -91.38 of the total average daily trading volume of 2.07 million.
Surface Oncology Inc. (NASDAQ:SURF) 2020 Performance Impressive
The increase in SURF’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of SURF currently stands at $7.66, which is higher than the current trading price of the stock by 14.36%. However, SURF’s current trading price is -470.43% lower than the 52-week low price of $1.15. In terms of trading volume, Surface Oncology Inc. currently experienced healthy participation during the last trading session. 1081627 shares of Surface Oncology Inc. were traded on the stock exchange on Tuesday, which is less than -91.38% of the 2.07 million average trading volume of the stock.
The performance of the stock has been positive over the past year. SURF’s performance over the past one year has seen it surge by 135.13%, while the stock has gone up by 236.41% in the last six months. The quarterly performance of SURF currently stands at 250.80%, and it is up by 30.16% in the last month. The only positive figure was from the weekly performance, which currently reads 28.88%. At the time of writing SURF’s report, the company has a total market cap of $205.07M, making it one of the largest publicly-traded companies in the world.Surface Oncology Inc. also has over 49 employees all over the world.
SURF Insider Activities
For Surface Oncology Inc., insiders hold 60.50% of all company shares. The insider transactions over the past six months are up by 4.70%. During that period, insiders bought 632,000 shares in 8 transactions. In that same period, insiders sold 420,000 of their shares in 1 transactions. After these transactions, insiders at Surface Oncology Inc. now hold 4.75M shares, which is over 62.75% of the total company stocks. Institutional investors currently hold a large chunk of the SURF shares, as they control 16.76% of the company’s total stock.
SURF Fundamental Analysis
For Surface Oncology Inc., the stock’s diluted earnings per share (EPS) stands at -1.09. In the coming year, analysts expect the EPS to be -1.98.
The Return on Investment (ROI) on Surface Oncology Inc.’s stock currently stands at -88.70%, and it has a net profit margin of -70.90%. The operating margin of the company is -71.20%.
At the moment, Surface Oncology Inc.’s Total Debt to Equity ratio stands at 0.06, and they have a long-term Debt to Equity ratio of 0.06.
SURF Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of SURF currently stands at 36.01%, while the SMA50 is 67.79%. The biggest one is the SMA200, which is currently reading 155.79% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 68.78.